Kaul I, Claxton A, Sawchak S, Sauder C, et al. Safety and Tolerability of Xanomeline and Trospium Chloride in Schizophrenia: Pooled Results From the 5-Week, Randomized, Double-Blind, Placebo-Controlled EMERGENT Trials. J Clin Psychiatry 2025;86:24m15497.
PMID: 40047530